Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Mafalda Abrantes

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Rheumatology (Oxford, England)|February 6, 2024
The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosusVeronica Venturelli, Ana Mafalda Abrantes, Anisur Rahman, et al.
Cureus|January 20, 2022
Immunosuppression Therapy in Acquired Hemophilia A: Pursuing an Optimal RegimenDúlio Teixeira Passos, Ana Mafalda Abrantes, Liliana Santos, et al.
Circulation Reports|August 20, 2021
Low-Dose Colchicine in Coronary Artery Disease - Systematic Review and Meta-AnalysisAna Mafalda Abrantes, Beatriz Nogueira-Garcia, Mariana Alves, et al.
Frontiers in Neurology|May 31, 2021
Does Parkinson's Disease Increase the Risk of Atrial Fibrillation? Insights From Electrocardiogram and Risk Scores From a Case-Control StudyMariana Alves, Ana Mafalda Abrantes, Gonçalo Portugal, et al.
International Journal of Hypertension|April 7, 2021
The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult InpatientsPedro Gaspar, Inês Parreira, Pedro Antunes Meireles, et al.
Lupus|April 15, 2024
Predictors of damage accrual and its impact on health-related quality of life of thrombotic antiphospholipid syndrome: Independent validation of the damage index for antiphospholipid syndrome (DIAPS)Pedro Gaspar, Ana Sofia M Fernandes, Ana Mafalda Abrantes, et al.
Renal Failure|March 30, 2023
C-reactive protein-to-albumin ratio and six-month mortality in incident hemodialysis patientsMariana Sant'Ana, Joana Gameiro, Cláudia Costa, et al.
European Journal of Case Reports in Internal Medicine|July 16, 2020
Erythematous Papular Rash: A Dermatological Feature of COVID-19Catarina Sousa Gonçalves, Nuno Reis Carreira, Dúlio Passos, et al.
Journal of Clinical Medicine|February 11, 2023
One-Year Mortality after Hemodialysis Initiation: The Prognostic Role of the CHA<sub>2</sub>DS<sub>2</sub>-VASc ScoreAna Mafalda Abrantes, Bernardo Marques da Silva, Carolina Branco, et al.
Lupus|November 17, 2025
Delayed diagnosis contributes to increased thrombotic burden and independently predicts severe organ damage in thrombotic antiphospholipid syndromeDiogo Santos, Ana Mafalda Abrantes, Filipa M Costa, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Rheumatology (Oxford, England)|February 6, 2024
The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosusVeronica Venturelli, Ana Mafalda Abrantes, Anisur Rahman, et al.
Cureus|January 20, 2022
Immunosuppression Therapy in Acquired Hemophilia A: Pursuing an Optimal RegimenDúlio Teixeira Passos, Ana Mafalda Abrantes, Liliana Santos, et al.
Circulation Reports|August 20, 2021
Low-Dose Colchicine in Coronary Artery Disease - Systematic Review and Meta-AnalysisAna Mafalda Abrantes, Beatriz Nogueira-Garcia, Mariana Alves, et al.
Frontiers in Neurology|May 31, 2021
Does Parkinson's Disease Increase the Risk of Atrial Fibrillation? Insights From Electrocardiogram and Risk Scores From a Case-Control StudyMariana Alves, Ana Mafalda Abrantes, Gonçalo Portugal, et al.
International Journal of Hypertension|April 7, 2021
The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult InpatientsPedro Gaspar, Inês Parreira, Pedro Antunes Meireles, et al.
Lupus|April 15, 2024
Predictors of damage accrual and its impact on health-related quality of life of thrombotic antiphospholipid syndrome: Independent validation of the damage index for antiphospholipid syndrome (DIAPS)Pedro Gaspar, Ana Sofia M Fernandes, Ana Mafalda Abrantes, et al.
Renal Failure|March 30, 2023
C-reactive protein-to-albumin ratio and six-month mortality in incident hemodialysis patientsMariana Sant'Ana, Joana Gameiro, Cláudia Costa, et al.
European Journal of Case Reports in Internal Medicine|July 16, 2020
Erythematous Papular Rash: A Dermatological Feature of COVID-19Catarina Sousa Gonçalves, Nuno Reis Carreira, Dúlio Passos, et al.
Journal of Clinical Medicine|February 11, 2023
One-Year Mortality after Hemodialysis Initiation: The Prognostic Role of the CHA<sub>2</sub>DS<sub>2</sub>-VASc ScoreAna Mafalda Abrantes, Bernardo Marques da Silva, Carolina Branco, et al.
Lupus|November 17, 2025
Delayed diagnosis contributes to increased thrombotic burden and independently predicts severe organ damage in thrombotic antiphospholipid syndromeDiogo Santos, Ana Mafalda Abrantes, Filipa M Costa, et al.
Pageof 2